top of page
Site Under Construction



Transformative Oral Medicines for Severe RNA-Mediated Diseases
Small molecules, big difference


Expansion Therapeutics has significantly expanded on scientific founder Matt Disney’s breakthrough work in addressing Small Molecules interacting with RNA (SMiRNA).
The World of SMiRNA™

Targeting RNA, Curing Disease
for Major Neurological Diseases
bottom of page